AviTrader sponsorship ad

Embraer announces the Phenom 300MED

©Embraer Phenom 300MED

Embraer has announced a Medevac solution for Phenom 300 series aircraft, the Phenom 300MED, which is also available for retrofit through a partnership with umlaut and Aerolite. Embraer and umlaut are jointly developing and certifying a new supplemental type certificate (STC) utilizing Aerolite equipment.

The Phenom 300MED, which is now available for customer configuration, is representative of Embraer’s modern and versatile product portfolio and the company’s intent to deliver the ultimate experience in business aviation, now including the Medevac segment. Designed as an ideal solution for both civil and government applications, the Medevac solution will be installed exclusively by Embraer’s Services & Support organization, ensuring the highest quality, reliability, and service experience, direct from the manufacturer.

Together, Embraer and umlaut are developing a comprehensive set of configuration alternatives for the Phenom 300MED, which will feature either one or two stretchers, as well as the ability to carry an incubator and additional medical equipment. The aircraft will also feature hospital-grade trim and finishing. As a purpose-built Medevac solution, created in collaboration with the leading companies in the industry, the Phenom 300MED is designed to be quickly and easily configured to meet the various needs of both healthcare providers and patients.

Share this Article
[avi_get_posts]

2026 MEDIA KIT

VP Sales & Business Development Americas
Tamar Jorssen
tamar.jorssen@avitrader.com
Phone: +1 (778) 213 8543
VP International Sales & Marketing
Malte Tamm
malte.tamm@avitrader.com
Phone: +49 (0)162 8263049

Subscribe to the most widely accepted news source in the aviation industry!


Free daily, weekly and monthly MRO publications delivered straight to your inbox!
News Alerts, Editorials, Marketplace, Expert Corner, Executive Interviews and more ...

Select publications:

*We respect your privacy and AviTrader will not share your email address with any third parties.